These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36418603)

  • 1. Examining the universality of the hemolysis power law model from simulations of the FDA nozzle using calibrated model coefficients.
    Mantegazza A; Tobin N; Manning KB; Craven BA
    Biomech Model Mechanobiol; 2023 Apr; 22(2):433-451. PubMed ID: 36418603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CFD-based Kriging surrogate modeling approach for predicting device-specific hemolysis power law coefficients in blood-contacting medical devices.
    Craven BA; Aycock KI; Herbertson LH; Malinauskas RA
    Biomech Model Mechanobiol; 2019 Aug; 18(4):1005-1030. PubMed ID: 30815758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification Benchmarks to Assess the Implementation of Computational Fluid Dynamics Based Hemolysis Prediction Models.
    Hariharan P; D'Souza G; Horner M; Malinauskas RA; Myers MR
    J Biomech Eng; 2015 Sep; 137(9):. PubMed ID: 26065371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the Interlaboratory Computational Fluid Dynamics Study of the FDA Benchmark Blood Pump.
    Ponnaluri SV; Hariharan P; Herbertson LH; Manning KB; Malinauskas RA; Craven BA
    Ann Biomed Eng; 2023 Jan; 51(1):253-269. PubMed ID: 36401112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-Eddy Simulations of Flow in the FDA Benchmark Nozzle Geometry to Predict Hemolysis.
    Tobin N; Manning KB
    Cardiovasc Eng Technol; 2020 Jun; 11(3):254-267. PubMed ID: 32297154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical implications of the erroneous treatment of exposure time in the Eulerian hemolysis power law model.
    Faghih MM; Craven BA; Sharp MK
    Artif Organs; 2023 Sep; 47(9):1531-1538. PubMed ID: 37032625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-Laboratory Characterization of the Velocity Field in the FDA Blood Pump Model Using Particle Image Velocimetry (PIV).
    Hariharan P; Aycock KI; Buesen M; Day SW; Good BC; Herbertson LH; Steinseifer U; Manning KB; Craven BA; Malinauskas RA
    Cardiovasc Eng Technol; 2018 Dec; 9(4):623-640. PubMed ID: 30291585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Accuracy of Hemolysis Models in Couette-Type Blood Shearing Devices.
    Wu P; Boehning F; Groß-Hardt S; Hsu PL
    Artif Organs; 2018 Oct; 42(10):E290-E303. PubMed ID: 30375677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modeling of the Food and Drug Administration's benchmark centrifugal blood pump.
    Good BC; Manning KB
    Artif Organs; 2020 Jul; 44(7):E263-E276. PubMed ID: 31971269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of flow-induced hemolysis using novel Couette-type blood-shearing devices.
    Zhang T; Taskin ME; Fang HB; Pampori A; Jarvik R; Griffith BP; Wu ZJ
    Artif Organs; 2011 Dec; 35(12):1180-6. PubMed ID: 21810113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Discretization of the Power-Law Hemolysis Model.
    Faghih MM; Islam A; Sharp MK
    J Biomech Eng; 2021 Jan; 143(1):. PubMed ID: 32793961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-based blood damage estimation for computational design of ventricular assist devices.
    Gesenhues L; Pauli L; Behr M
    Int J Artif Organs; 2016 Jun; 39(4):166-70. PubMed ID: 27079416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Eulerian and Lagrangian models for hemolysis estimation.
    Taskin ME; Fraser KH; Zhang T; Wu C; Griffith BP; Wu ZJ
    ASAIO J; 2012; 58(4):363-72. PubMed ID: 22635012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the representation of effective stress for computing hemolysis.
    Wu P; Gao Q; Hsu PL
    Biomech Model Mechanobiol; 2019 Jun; 18(3):665-679. PubMed ID: 30604300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA Benchmark Medical Device Flow Models for CFD Validation.
    Malinauskas RA; Hariharan P; Day SW; Herbertson LH; Buesen M; Steinseifer U; Aycock KI; Good BC; Deutsch S; Manning KB; Craven BA
    ASAIO J; 2017; 63(2):150-160. PubMed ID: 28114192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilaboratory study of flow-induced hemolysis using the FDA benchmark nozzle model.
    Herbertson LH; Olia SE; Daly A; Noatch CP; Smith WA; Kameneva MV; Malinauskas RA
    Artif Organs; 2015 Mar; 39(3):237-48. PubMed ID: 25180887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Transitional and Turbulent Flow Through the FDA Benchmark Nozzle Model Using Laser Doppler Velocimetry.
    Taylor JO; Good BC; Paterno AV; Hariharan P; Deutsch S; Malinauskas RA; Manning KB
    Cardiovasc Eng Technol; 2016 Sep; 7(3):191-209. PubMed ID: 27350137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilaboratory particle image velocimetry analysis of the FDA benchmark nozzle model to support validation of computational fluid dynamics simulations.
    Hariharan P; Giarra M; Reddy V; Day SW; Manning KB; Deutsch S; Stewart SF; Myers MR; Berman MR; Burgreen GW; Paterson EG; Malinauskas RA
    J Biomech Eng; 2011 Apr; 133(4):041002. PubMed ID: 21428676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations.
    Hariharan P; D'Souza GA; Horner M; Morrison TM; Malinauskas RA; Myers MR
    PLoS One; 2017; 12(6):e0178749. PubMed ID: 28594889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of mechanical hemolysis in medical devices via a Lagrangian strain-based multiscale model.
    Nikfar M; Razizadeh M; Zhang J; Paul R; Wu ZJ; Liu Y
    Artif Organs; 2020 Aug; 44(8):E348-E368. PubMed ID: 32017130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.